ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia and rheumatoid arthritis (RA)"

  • Abstract Number: 230 • 2019 ACR/ARP Annual Meeting

    Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study

    Fabiola Atzeni1, Mariateresa Cirillo 2, Ignazio Francesco Masala 3, Piercarlo Sarzi-Puttini 4 and Alessandra Alciati 5, 1Rheumatology Unit, University of Messina, Messina, Italy., Messina, Italy, 2Rheumatology Unit, University of Messina, Italy, Messina, Italy, 3Orthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy, Cagliari, Italy, 4Rheumatology Unit, L.Sacco University Hopsital, Milan, Italy, Milan, Italy, 5Department of Clinical Neurosciences , Villa San Benedetto Menni, Hermanas Hospitalarias, FoRiPsi , Como , Italy and Humanitas Clinical and Research Center , Rozzano (Milan) , Italy., Milan, Italy

    Background/Purpose: The aim  was to evaluate the differences in depression-, anxiety- and stress-related events and trauma between patients with rheumatoid arthritis + Fibromyalgia [AR+FM] (SFM)…
  • Abstract Number: 257 • 2019 ACR/ARP Annual Meeting

    Alcohol Use Hospitalizations in People with Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain Are Increasing: A Time-trends Study Using the U.S. National Data

    Jasvinder Singh1 and john Cleveland 2, 1University of Alabama Medical Center, Birmingham, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Alcohol abuse and associated mortality is an important public health problem in the U.S. To our knowledge, limited data are available on alcohol use…
  • Abstract Number: 239 • 2018 ACR/ARHP Annual Meeting

    Outcomes of Hospitalizations and the Temporal Trends in Mortality from Acute Myocardial Infarction in Patients with RA and FM during 2005 to 2015

    Atefeh Vafa1, Setri Fugar2 and John P. Case3,4, 1Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Cardiology, Rush University Medical Center, Chicago, IL, 3Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 4Internal Medicine, Chicago Medical School, North Chicago, IL

    Background/Purpose: RA is associated with an increased risk of coronary artery disease (CAD). This association is believed to be due to systemic inflammation and its…
  • Abstract Number: 163 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia Patients Identify More Causes of Disease Flare Ups Than RA Patients

    Robert S. Katz1, Lauren Kwan2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:   We compared patients with the Fibromyalgia Syndrome (FMS) and Rheumatoid Arthritis (RA) patients with respect to stresses that the patients believe may have caused…
  • Abstract Number: 2753 • 2017 ACR/ARHP Annual Meeting

    Brain Functional Connectivity Features of Pain Centralisation Relate to Degree of ‘Fibromyalgianess’ in Rheumatoid Arthritis

    Neil Basu1, Chelsea Cummiford2, Eric Ichesco2, Tony Larkin2, Richard E. Harris2, Alison Murray3, Gordon Waiter4 and Daniel J. Clauw5, 1Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom, 2Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 3Aberdeen Brain Imaging Center, University of Aberdeen, Aberdeen, United Kingdom, 4Aberdeen Brain Imaging Centre, University of Aberdeen, Aberdeen, United Kingdom, 5Anesthesiology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Many rheumatoid arthritis (RA) patients continue to report pain despite excellent control of inflammation with immunotherapy regimes. Variable degrees of co-existing fibromyalgia (FM) may…
  • Abstract Number: 1523 • 2016 ACR/ARHP Annual Meeting

    The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR

    Luis I Lozano-Plata1, David Vega-Morales2, Ana Arana-Guajardo3, Mario Alberto Garza-Elizondo4, Cassandra Skinner-Taylor4, Roberto Negrete-López1, Jorge Esquivel-Valerio5 and Miguel A Villarreal-Alarcón6, 1Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, 3Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 6Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. Jose Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: The disease activity score (DAS) is a method used to monitor disease activity in Rheumatoid Arthritis (RA). Diseases that cause chronic pain or mood…
  • Abstract Number: 2203 • 2016 ACR/ARHP Annual Meeting

    Self-Reported Childhood Maltreatment and Traumatic Events Among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis

    Raneen Hellou1, Winfried Häuser2, Inbal Brenner3, Dan Buskila4, Giris Jacob5, Ori Elkayam6, Valerie Aloush7 and Jacob N. Ablin8, 1Internal medicine F, Tel Aviv Sourasky Medical center, Tel Aviv, Israel, 2Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, 3Shalvata Mental Health Center, Hod Hasharon, Israel, 4Internal Medicine, Soroka Medical Center, Beer Sheva, Israel, 5Internal medicine F, Tel Aviv Sourasky medical center, Zichron Yakov, Israel, 6Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 7Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 8Institute of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Abstract: Background/Purpose: the association between Fibromyalgia Syndrome (FMS) and childhood maltreatment and adversity has frequently been proposed but limited data exists regarding the trans-cultural nature…
  • Abstract Number: 2220 • 2016 ACR/ARHP Annual Meeting

    Impact of Fibromyalgia on DAS28 in Patients with Rheumatoid Arthritis

    Aman Sharma1, Ashish Aggarwal2, Eyal Kedar3, Mary Bach4 and Shounak Lahiri5, 1Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 2PGIMER, Chandigarh, Chandigarh, India, 3St. Lawrence Health System, Potsdam, NY, 4VA Puget Sound Health Care System, Seattle, WA, 5Twistle Inc., Albuquerque, NM

    Background/Purpose:  To estimate the prevalence of secondary fibromyalgia (FM) in patients with RA and its effect on the disease activity score (DAS28) in a tertiary…
  • Abstract Number: 66 • 2015 ACR/ARHP Annual Meeting

    Fibromyalgia Patients Identify More Causes of Disease Flare Ups Than RA Patients

    Robert S. Katz1, Lauren Kwan2, Hannah Leavitt2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose: Flare-ups are a frequent and painful part of FMS and RA. We compared FMS and RA patients with respect to stresses that the patients…
  • Abstract Number: 3089 • 2015 ACR/ARHP Annual Meeting

    Evaluation of Learned Helplessness, Perceived Self-Efficacy and Functional Capacity in Patients with Fibromyalgia and Rheumatoid Arthritis

    Sebastian Moyano1, Marina Scolnik1, Facundo Vergara1, Maria Victoria Garcia2, Mirtha Sabelli3, Javier Rosa4 and Enrique R. Soriano5, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Internal Services, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 3Cabrera 2964 Piso 6, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 4Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: Chronic diseases involve cognitive and emotional aspects of patients. One relevant cognitive factor is the learned helplessness (LH), defined as an inadequate perception of…
  • Abstract Number: 2683 • 2013 ACR/ARHP Annual Meeting

    Application Of a Multi-Biomarker Disease Activity (Vectra® DA) Score For Assessing Rheumatoid Arthritis Patients With Fibromyalgia Or Low C-Reactive Protein

    Yvonne C. Lee1, James Hackett2, Claire Alexander3, Michelle A. Frits1, Christine K. Iannaccone1, Nancy A. Shadick4, Michael E. Weinblatt5, Oscar Segurado6 and Eric H. Sasso6, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Hackett & Associates, Inc., San Diego, CA, 3Clinical Operations, Crescendo Bioscience Inc., South San Francisco, CA, 4Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 5Division of Rheumatology & Immunology, Brigham and Women's Hospital, Boston, MA, 6Crescendo Bioscience Inc., South San Francisco, CA

    Background/Purpose: Clinical assessment of rheumatoid arthritis (RA) may be challenging if patients have fibromyalgia (FM) or if C-reactive protein (CRP) is low (£1 mg/dL). A…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology